172 related articles for article (PubMed ID: 20837358)
1. Fluvastatin and cisplatin demonstrate synergistic cytotoxicity in epithelial ovarian cancer cells.
Taylor-Harding B; Orsulic S; Karlan BY; Li AJ
Gynecol Oncol; 2010 Dec; 119(3):549-56. PubMed ID: 20837358
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
[TBL] [Abstract][Full Text] [Related]
3. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
[TBL] [Abstract][Full Text] [Related]
4. Combination of Tetrandrine with cisplatin enhances cytotoxicity through growth suppression and apoptosis in ovarian cancer in vitro and in vivo.
Zhang Y; Wang C; Wang H; Wang K; Du Y; Zhang J
Cancer Lett; 2011 May; 304(1):21-32. PubMed ID: 21333438
[TBL] [Abstract][Full Text] [Related]
5. Statin-induced inhibition of MCF-7 breast cancer cell proliferation is related to cell cycle arrest and apoptotic and necrotic cell death mediated by an enhanced oxidative stress.
Sánchez CA; Rodríguez E; Varela E; Zapata E; Páez A; Massó FA; Montaño LF; Lóopez-Marure R
Cancer Invest; 2008 Aug; 26(7):698-707. PubMed ID: 18608208
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor receptor I targeting in epithelial ovarian cancer.
Gotlieb WH; Bruchim I; Gu J; Shi Y; Camirand A; Blouin MJ; Zhao Y; Pollak MN
Gynecol Oncol; 2006 Feb; 100(2):389-96. PubMed ID: 16300820
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C inhibitor Gö6976 augments caffeine-induced reversal of chemoresistance to cis-diamminedichloroplatinum-II (CDDP) in a human ovarian cancer model.
Qamar L; Davis R; Anwar A; Behbakht K
Gynecol Oncol; 2008 Sep; 110(3):425-31. PubMed ID: 18619662
[TBL] [Abstract][Full Text] [Related]
8. In-vitro synergism of m-TOR inhibitors, statins, and classical chemotherapy: potential implications in acute leukemia.
Calabro A; Tai J; Allen SL; Budman DR
Anticancer Drugs; 2008 Aug; 19(7):705-12. PubMed ID: 18594212
[TBL] [Abstract][Full Text] [Related]
9. [Proteasome inhibitors sensitize ovarian cancer cells to cisplatin].
Li Y; Weng DH; Kong FF; Fan LS; Hu Y; Song XH; Xing H; Wang W; Ma D; Wang SX
Zhonghua Fu Chan Ke Za Zhi; 2010 Jun; 45(6):445-8. PubMed ID: 21029596
[TBL] [Abstract][Full Text] [Related]
10. Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells.
Horváth V; Blanárová O; Svihálková-Sindlerová L; Soucek K; Hofmanová J; Sova P; Kroutil A; Fedorocko P; Kozubík A
Gynecol Oncol; 2006 Jul; 102(1):32-40. PubMed ID: 16364413
[TBL] [Abstract][Full Text] [Related]
11. EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer.
Huether A; Höpfner M; Baradari V; Schuppan D; Scherübl H
Biochem Pharmacol; 2005 Nov; 70(11):1568-78. PubMed ID: 16226226
[TBL] [Abstract][Full Text] [Related]
12. Spermidine/spermine N1-acetyltranferase modulation by novel folate cycle inhibitors in cisplatin-sensitive and -resistant human ovarian cancer cell lines.
Marverti G; Ligabue A; Guerrieri D; Paglietti G; Piras S; Costi MP; Farina D; Frassineti C; Monti MG; Moruzzi MS
Gynecol Oncol; 2010 May; 117(2):202-10. PubMed ID: 20031193
[TBL] [Abstract][Full Text] [Related]
13. Fluvastatin and lovastatin but not pravastatin induce neuroglial differentiation in human mesenchymal stem cells.
Lee OK; Ko YC; Kuo TK; Chou SH; Li HJ; Chen WM; Chen TH; Su Y
J Cell Biochem; 2004 Nov; 93(5):917-28. PubMed ID: 15389871
[TBL] [Abstract][Full Text] [Related]
14. Fluvastatin enhancement of trastuzumab and classical cytotoxic agents in defined breast cancer cell lines in vitro.
Budman DR; Tai J; Calabro A
Breast Cancer Res Treat; 2007 Jul; 104(1):93-101. PubMed ID: 17004104
[TBL] [Abstract][Full Text] [Related]
15. Statin-induced apoptosis linked with membrane farnesylated Ras small G protein depletion, rather than geranylated Rho protein.
Matzno S; Yasuda S; Juman S; Yamamoto Y; Nagareya-Ishida N; Tazuya-Murayama K; Nakabayashi T; Matsuyama K
J Pharm Pharmacol; 2005 Nov; 57(11):1475-84. PubMed ID: 16259781
[TBL] [Abstract][Full Text] [Related]
16. Enhanced sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to the combination of cisplatin and synthetic isothiocyanate ethyl 4-isothiocyanatobutanoate.
Bodo J; Chovancova J; Hunakova L; Sedlak J
Neoplasma; 2005; 52(6):510-6. PubMed ID: 16284698
[TBL] [Abstract][Full Text] [Related]
17. Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agents.
Goard CA; Mather RG; Vinepal B; Clendening JW; Martirosyan A; Boutros PC; Sharom FJ; Penn LZ
Int J Cancer; 2010 Dec; 127(12):2936-48. PubMed ID: 21351272
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-targeted nitroxides exacerbate fluvastatin-mediated cytostatic and cytotoxic effects in breast cancer cells.
Cheng G; Lopez M; Zielonka J; Hauser AD; Joseph J; McAllister D; Rowe JJ; Sugg SL; Williams CL; Kalyanaraman B
Cancer Biol Ther; 2011 Oct; 12(8):707-17. PubMed ID: 21799303
[TBL] [Abstract][Full Text] [Related]
19. Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells.
Lee KW; Kim SG; Kim HP; Kwon E; You J; Choi HJ; Park JH; Kang BC; Im SA; Kim TY; Kim WH; Bang YJ
Cancer Res; 2008 Mar; 68(6):1916-26. PubMed ID: 18339873
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis.
Nagashima T; Okazaki H; Yudoh K; Matsuno H; Minota S
Arthritis Rheum; 2006 Feb; 54(2):579-86. PubMed ID: 16447234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
